Show simple item record

dc.contributor.authorRead, Graham Ren
dc.contributor.authorJohnson, Richard Jen
dc.contributor.authorWilkinson, Peter Men
dc.contributor.authorEddleston, Brianen
dc.date.accessioned2014-12-09T12:09:35Z
dc.date.available2014-12-09T12:09:35Z
dc.date.issued1983-11-19
dc.identifier.citationProspective study of follow up alone in stage I teratoma of the testis. 1983, 287 (6404):1503-5 Br Med J (Clin Res Ed)en
dc.identifier.issn0267-0623
dc.identifier.pmid6196076
dc.identifier.urihttp://hdl.handle.net/10541/336953
dc.description.abstractIn a prospective surveillance study of 45 patients with stage I teratoma of the testis 34 (76%) required no further treatment. Eleven patients relapsed but were salvaged by chemotherapy and radiotherapy. Seven patients relapsed within three months of the initial assessment and only one after more than 12 months. These preliminary results suggest that a follow up policy in stage I teratoma of the testis is possible but only in a regional centre with facilities for close monitoring of patients.
dc.language.isoenen
dc.rightsArchived with thanks to British medical journal (Clinical research ed.)en
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshBleomycin
dc.subject.meshCastration
dc.subject.meshCisplatin
dc.subject.meshEtoposide
dc.subject.meshHumans
dc.subject.meshLung Neoplasms
dc.subject.meshMale
dc.subject.meshPrednisolone
dc.subject.meshProspective Studies
dc.subject.meshTeratoma
dc.subject.meshTesticular Neoplasms
dc.subject.meshVinblastine
dc.subject.meshVindesine
dc.titleProspective study of follow up alone in stage I teratoma of the testis.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital and Holt Radium Institute, Manchester M20 9BXen
dc.identifier.journalBritish Medical Journalen
html.description.abstractIn a prospective surveillance study of 45 patients with stage I teratoma of the testis 34 (76%) required no further treatment. Eleven patients relapsed but were salvaged by chemotherapy and radiotherapy. Seven patients relapsed within three months of the initial assessment and only one after more than 12 months. These preliminary results suggest that a follow up policy in stage I teratoma of the testis is possible but only in a regional centre with facilities for close monitoring of patients.


This item appears in the following Collection(s)

Show simple item record